Scientists search for early warning signs in blood to predict lung cancer return
NCT ID NCT05415358
Summary
This study aims to learn if certain markers in the blood can predict whether lung cancer will return after patients finish a standard course of immunotherapy. Researchers will follow 23 patients who have completed about two years of treatment, collecting their blood every few months to look for these signals. The goal is to gather knowledge that could one day help doctors monitor patients more effectively after treatment ends.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER, NONSMALL CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Levine Cancer
Charlotte, North Carolina, 28204, United States
-
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.